Resources
Consensus Statements + Guidelines
Joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society.
https://onlinelibrary.wiley.com/doi/10.1002/oby.24336
Nestle Health Science
Nutritional considerations with antiobesity medications
NICE
Semaglutide for managing overweight and obesity
Advice and support after stopping medicines for weight management or completing behavioural interventions
BDA
Joint statement regarding GLP-1/GIP Receptor Agonists for people living with obesity and/or type 2 diabetes
Academy of Nutrition & Dietetics
“The Evolving Role of Registered Dietitian Nutritionists in Obesity Management with Medications and Lifestyle Interventions”
https://www.jandonline.org/article/S2212-2672(24)00925-0/fulltext
Webinars
Academy of Nutrition & Dietetics
The Role of the RDN to Optimize Short- and Long-term Use of Anti-Obesity Medications
The Impact of Obesity Medications on Chronic Disease Management: From Research to Practice
Considerations for Body Composition, Physical Activity and Nutrition with Use of Obesity Medications
Podcasts
Acquired Podcast
The Complete History & Strategy of Novo Nordisk
Wall Street Journal Podcast
The Drive: Peter Attia
Huberman Lab